Charles River Laboratories | CRL - 流动负债

股票价格
173.89
每天变化
-1.01 -0.58%
每月一次
-1.02%
每年
23.34%
Q2 预测
168.66


金融业
股票价格
USD
资产
USD 7.14B
现金及等价物
USD 213.77M
销售成本
USD 722.27M
流动资产
USD 1.45B
流动负债
USD 1.12B
债务
USD 2.63B
EBIT
USD 75.82M
EBITDA
USD 258.06M
员工
18.6K
EPS每股收益
USD 2.39
股本和储备
USD 3.16B
销售毛利
USD 271.96M
债务利息支出
USD 23.78M
利息收入
USD 1.1
贷款资金
USD 2.14B
市值
USD 8.89B
净收入
USD -276.56M
营业费用
USD 918.41M
营业利润
USD 75.82M
普通股股本
USD 49.22M
PE价格收益
43.58
税前利润
USD 170.03M
销售收入
USD 994.2M
销售和管理费用
USD 196.14M
股票
USD 299.1M
贸易债权人
USD 148.8M
应收帐款人
USD 1.43B


流动负债 更改 日
Agilent USD 2.23B 113M 2025-12
Align Technology USD 1.92B 46.45M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Cardinal Health USD 43.31B 3.05B 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Cigna USD 56.34B 111M 2025-12
Concord Medical Services Hldg CNY 2.45B 1.12B 2025-06
CVS Health USD 88.69B 4B 2025-12
Danaher USD 6.81B 483M 2025-12
Dentsply International USD 1.34B 62M 2025-12
Elevance Health USD 41.04B 157M 2025-12
Galapagos EUR 152.86M 213.7M 2025-12
Hologic USD 951.3M 25.9M 2025-12
Humana USD 16.35B 166M 2025-12
Illumina USD 1.59B 377M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Lonza CHF 3.57B 421M 2025-12
McKesson USD 68.13B 100M 2025-12
Merck EUR 9.04B 405M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Quest Diagnostics USD 2.28B 144M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
United Therapeutics USD 560.6M 14.3M 2025-12
UnitedHealth USD 115.53B 4.74B 2025-09
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 654.9M 19.5M 2025-12